Provectus Biopharmaceutica-APVCT
13F holders, Q1 2024 (March 31)6holders
$0.18avg. 13F price*
At the end of Q1 2024, 6 institutions reported holding Provectus Biopharmaceutica-A (PVCT) in their 13F filings. The largest holders were Home Federal Bank of Tennessee ($18K), Atlas Wealth LLC ($5K) and LBMC Investment Advisors, LLC ($4K).
- Company
- Provectus Biopharmaceutica-A
- CUSIP
- 74373P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 6 holders
| Home Federal Bank of Tennessee | 0.01% | No change | 100,000 | $18K |
| Atlas Wealth LLC | 0.00% | No change | 26,620 | $5K |
| LBMC Investment Advisors, LLC | 0.00% | No change | 22,000 | $4K |
| Academy Capital Management | 0.00% | No change | 20,000 | $4K |
| Financial Symmetry Inc | 0.00% | No change | 10,191 | $2K |
| Huntington National Bank | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is PVCT's weight in each manager's 13F, not the share of Provectus Biopharmaceutica-A the manager owns.